An ongoing dialogue on HIV/AIDS, infectious diseases,
January 4th, 2009
Top Stories in HIV Medicine
Happy New Year!
In the spirit of list-making that seems to permeate the world right about this time, we’ve just published our own list over at AIDS Clinical Care. Check it out — our editorial board this year did a superb job of summarizing the field.
I have a strong feeling that next year’s version will have some much more hopeful news on prevention, perhaps through pre-exposure prophylaxis (PrEP), or treatment as prevention, or both.
As for advances in vaccines, um … perhaps the less said the better?
Paul E. Sax, MD
Learn more about HIV and ID Observations.
Follow HIV and ID Observations Posts via Email
- ID Cartoon Caption Contest (125)
- ID Cartoon Caption Contest #2 Winner — and a New Contest for the Holidays (92)
- Dear Nation — A Series of Apologies on COVID-19 (80)
- How to Induce Rage in a Doctor (77)
- IDSA’s COVID-19 Treatment Guidelines Highlight Difficulty of “Don’t Just Do Something, Stand There” (74)
- Laying Some Spurious COVID-19 Treatments to Rest
- Optimizing Antibiotics for DAIR
- To Expand and Sustain PrEP, Make Better Use of Walk-In Care and Nonmedical Staff at Sexual Health Clinics
- Observations from ID and Beyond: Story as Evidence — Our Story
- Do Antibiotics Diminish Innate Immunity by Attenuating Toll-Like Receptor Activity?
- Abacavir AIDS antibiotics antiretroviral therapy ART atazanavir baseball CDC C diff COVID-19 CROI cure darunavir dolutegravir elvitegravir etravirine FDA HCV hepatitis C HIV HIV cure HIV testing ID fellowship ID Learning Unit Infectious Diseases influenza Link-o-Rama lyme disease MRSA PEP Policy PrEP prevention primary care raltegravir Really Rapid Review resistance Retrovirus Conference rilpivirine sofosbuvir TDF/FTC tenofovir Thanksgiving vaccines zoster